Cytokinetics (CYTK)
NASDAQ: CYTK
· Real-Time Price · USD
38.37
-0.35 (-0.90%)
At close: Aug 15, 2025, 1:29 PM
Cytokinetics Fail-to-Deliver
Total FTD Shares
11.71K
Below Average
FTD / Avg. Volume
0.71%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 10, 2025,
Cytokinetics has
11,707
shares failed to deliver, representing 0.71%
of the average daily volume of
1,645,202.9
shares. Over the past year, the monthly average FTD is
11,890
shares, with the current level 2% below
the historical average, indicating
moderate
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 10, 2025 | 36.59 | 11.71K | +490.67% |
| Jun 25, 2025 | 33.11 | 1.98K | -96.91% |
| May 28, 2025 | 30.28 | 64.13K | +859.90% |
| Apr 25, 2025 | 40.43 | 6.68K | +876.75% |
| Mar 31, 2025 | 40.19 | 684 | -98.75% |
| Feb 25, 2025 | 46.65 | 54.53K | +414.44% |
| Jan 31, 2025 | 49.46 | 10.6K | -64.67% |
| Dec 23, 2024 | 48.95 | 30K | +67.08% |
| Nov 26, 2024 | 52.02 | 17.95K | +824.56% |
| Oct 16, 2024 | 55.28 | 1.94K | -89.05% |
| Sep 24, 2024 | 52.66 | 17.74K | +514.59% |
| Aug 30, 2024 | 57.08 | 2.89K | +366.99% |
| Jul 24, 2024 | 56.8 | 618 | -38.32% |
| Jun 25, 2024 | 52.87 | 1K | -99.60% |
| May 28, 2024 | 48.21 | 248.26K | +695.72% |
| Apr 25, 2024 | 64.8 | 31.2K | +6895.29% |
| Mar 27, 2024 | 71.41 | 446 | -98.55% |
| Feb 29, 2024 | 72.24 | 30.79K | -69.14% |
| Jan 30, 2024 | 78.73 | 99.77K | +640.82% |
| Dec 29, 2023 | 83.49 | 13.47K | +67240.00% |
| Nov 24, 2023 | 31.97 | 20 | -99.93% |
| Oct 27, 2023 | 31.74 | 30.43K | +1915.30% |
| Sep 25, 2023 | 29.98 | 1.51K | +247.13% |
| Aug 14, 2023 | 32.1 | 435 | -46.69% |
| Jul 26, 2023 | 32.4 | 816 | +247.23% |
| Jun 27, 2023 | 33.75 | 235 | +135.00% |
| May 25, 2023 | 37.54 | 100 | -94.13% |
| Apr 24, 2023 | 38.32 | 1.7K | -90.68% |
| Mar 31, 2023 | 35.19 | 18.27K | +667.24% |
| Feb 27, 2023 | 42.98 | 2.38K | +651.10% |
| Jan 30, 2023 | 41.06 | 317 | n/a |